ArticleJournal of translational medicine2021

Niraparib exhibits a synergistic anti-tumor effect with PD-L1 blockade by inducing an immune response in ovarian cancer.

Jinyu Meng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.